Literature DB >> 19449168

The human leukocyte antigen class I genes in nasopharyngeal carcinoma risk.

Elham Hassen1, Ghandri Nahla, Noureddine Bouaouina, Lotfi Chouchane.   

Abstract

Nasopharyngeal carcinoma (NPC) is a virally associated cancer which is highly prevalent in Southeast Asia and North Africa. Several linkage analysis studies suggested the association of susceptibility HLA (Human Leukocyte Antigen) alleles and haplotypes with NPC development. The HLA system is very polymorphic and according to the ethnic group studied, it has been found to have the capacity to confer susceptibility or resistance to NPC. Our aim was to review the most important described genetic associations of HLA class I in NPC and to comment on the inconsistent associations found in the different NPC incidence areas. We believe that the mechanisms of these associations may involve HLA genes through the differential capacity of each allele to present antigens. However, because HLA genes contain various linked candidate genes, HLA-NPC associations should be carefully interpreted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19449168     DOI: 10.1007/s11033-009-9548-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  69 in total

1.  Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas.

Authors:  A Khabir; A Sellami; M Sakka; A M Ghorbel; J Daoud; M Frikha; M M Drira; P Busson; R Jlidi
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

Review 2.  Host and viral genetics and risk of cervical cancer: a review.

Authors:  Allan Hildesheim; Sophia S Wang
Journal:  Virus Res       Date:  2002-11       Impact factor: 3.303

3.  Cancer Incidence in Five Continents. Comparability and quality of data.

Authors:  D M Parkin; C S Muir
Journal:  IARC Sci Publ       Date:  1992

4.  Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.

Authors:  R Gavioli; P O De Campos-Lima; M G Kurilla; E Kieff; G Klein; M G Masucci
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

5.  Screening for family members of patients with nasopharyngeal carcinoma.

Authors:  Wai-Tong Ng; Tsz-Kok Yau; Raymond W H Yung; Wai-Man Sze; Abby H L Tsang; Ada L Y Law; Anne W M Lee
Journal:  Int J Cancer       Date:  2005-03-01       Impact factor: 7.396

6.  HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.

Authors:  R S Midgley; A I Bell; Q Y Yao; D Croom-Carter; A D Hislop; B M Whitney; A T C Chan; P J Johnson; A B Rickinson
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

7.  Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity.

Authors:  Eri Seto; Tadamasa Ooka; Jaap Middeldorp; Kenzo Takada
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

8.  A protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in US Caucasians.

Authors:  R D Burt; T L Vaughan; B Nisperos; M Swanson; M Berwick
Journal:  Int J Cancer       Date:  1994-02-15       Impact factor: 7.396

9.  Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population.

Authors:  Hayet Douik; Arij Ben Chaaben; Neila Attia Romdhane; Habiba Ben Romdhane; Tesnim Mamoghli; Catherine Fortier; Wahid Boukouaci; Latifa Harzallah; Abderraouf Ghanem; Said Gritli; Mohamed Makni; Dominique Charron; Rajagopal Krishnamoorthy; Fethi Guemira; Ryad Tamouza
Journal:  Hum Immunol       Date:  2008-11-08       Impact factor: 2.850

10.  Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese.

Authors:  S P Hu; N E Day; D R Li; R N Luben; K L Cai; T Ou-Yang; B Li; X Z Lu; B A J Ponder
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

View more
  7 in total

1.  The association between a single nucleotide polymorphism rs11966200 in MHC region and clinical features of generalized vitiligo in Chinese Han population.

Authors:  Jin Tang; Jian Lan Liu; Cheng Zhang; Da Yan Hu; Su Min He; Xian Bo Zuo; Pei Guang Wang; Liang Dan Sun; Xue Jun Zhang; Sen Yang
Journal:  Mol Biol Rep       Date:  2013-03-21       Impact factor: 2.316

2.  Molecular docking to identify associations between drugs and class I human leukocyte antigens for predicting idiosyncratic drug reactions.

Authors:  Heng Luo; Tingting Du; Peng Zhou; Lun Yang; Hu Mei; Huiwen Ng; Wenqian Zhang; Mao Shu; Weida Tong; Leming Shi; Donna L Mendrick; Huixiao Hong
Journal:  Comb Chem High Throughput Screen       Date:  2015       Impact factor: 1.339

3.  Large scale analysis of phenotype-pathway relationships based on GWAS results.

Authors:  Aharon Brodie; Oholi Tovia-Brodie; Yanay Ofran
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

4.  Associations of Human Leukocyte Antigen-DRB1 Alleles with Nasopharyngeal Carcinoma and Its Clinical Significance in Xinjiang Uyghur Autonomous Region of China.

Authors:  Xiao-Tao Geng; Yun-Hui Hu; Tao Dong; Ruo-Zheng Wang
Journal:  Chin Med J (Engl)       Date:  2016-06-05       Impact factor: 2.628

5.  Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma.

Authors:  Adel M Zaatar; Chun Ren Lim; Chin Wei Bong; Michelle Mei Lin Lee; Jian Jiek Ooi; David Suria; Rakesh Raman; Samuel Chao; Hengxuan Yang; Soon Bin Neoh; Choong-Chin Liew
Journal:  J Exp Clin Cancer Res       Date:  2012-09-17

6.  How genome-wide SNP-SNP interactions relate to nasopharyngeal carcinoma susceptibility.

Authors:  Wen-Hui Su; Yin Yao Shugart; Kai-Ping Chang; Ngan-Ming Tsang; Ka-Po Tse; Yu-Sun Chang
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

7.  HLA Class I Allele Frequencies in Southern Iranian Women with Breast Cancer.

Authors:  Mahboobeh Razmkhah; Abbas Ghaderi
Journal:  Iran J Basic Med Sci       Date:  2013-02       Impact factor: 2.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.